(This story has been up to date to incorporate a press release from the Royal Canadian Mounted Police. – Ed)
Health Canada suspended Bonify’s authority to promote marijuana after an investigation discovered the Winnipeg-based agency possessed, distributed and sold product bought from an illegal supply, the regulatory company confirmed to Marijuana Business Daily.
“Following a review of recent activities by Bonify Medical Cannabis, Health Canada suspended the company’s authority to sell cannabis to protect public health and public safety,” Health Canada wrote in an e-mail.
“As a result of this suspension, Bonify Medical Cannabis must immediately suspend sales of all cannabis for both medical and nonmedical purposes.”
The suspension occurred Feb. four, with Health Canada citing noncompliance with the Cannabis Act.
The federal well being division referred the matter to the Royal Canadian Mounted Police and notified the Canada Revenue Agency, in addition to approved cannabis distributors, of the choice.
Bonify has 10 days to attraction the choice.
According to a discover on Bonify’s web site: “Product ordering is temporarily on hold.”
“This enforcement action reinforces the importance of Health Canada’s regular inspections of cannabis license holders to identify noncompliance and to protect the integrity of Canada’s legal cannabis production system,” the company’s assertion stated.
Manitoba RCMP spokeswoman Tara Seel stated police are assessing info obtained concerning the Bonify matter.
“The RCMP continues to conduct a review of this information and will determine the scope of a subsequent investigation, if any, upon completion of the review,” she stated in an e-mail.
The suspension follows a sequence of occasions that has unfolded over the previous a number of months:
- Winnipeg Free Press first reported in December that Bonify allegedly purchased illegal cannabis and sold it in government-regulated channels.
- The Liquor, Gaming and Cannabis Authority (LGCA) of Manitoba seized Bonify’s cannabis merchandise from retailers, calling them “illegal.”
- A 3rd-party investigation was launched by RavenQuest Technologies, which discovered that Bonify sold unauthorized cannabis merchandise in Saskatchewan.
- In December, Bonify recalled 52 models of product, saying it might not meet a number of the microbial and chemical contaminant limits as specified by the Good Production Practices necessities within the Cannabis Regulations.
- On Dec. 21, Bonify stated it retained the administration providers of RavenQuest BioMed, together with operational path and oversight for Bonify’s 320,000-square-foot cannabis manufacturing facility in Winnipeg.
- Bonify recalled roughly 5,883 models of product on Dec. 24 due to labeling errors and recordkeeping points with manufacturing paperwork that will not meet the necessities underneath the Cannabis Regulations.
Bonify’s contract with RavenQuest expires March 31.
George Robinson, appearing CEO of Bonify and RavenQuest’s CEO, stated RavenQuest will request an extension with Bonify after which attraction the suspension.
“I think we have a very strong position,” he stated. “It’s my sense that it’s favorable to us that this would happen.”
Matt Lamers might be reached at [email protected]
To join our weekly worldwide cannabis enterprise publication, click on right here.